Development of organizational and economic approaches to the analysis of efficiency of activities of pharmacy as subjects of insurance relations in national health care
Journal Title: ScienceRise: Pharmaceutical Science - Year 2019, Vol 0, Issue 4
Abstract
<p><strong>Aim</strong>: to develop a set of organizational and economic approaches to analyzing the effectiveness of pharmacy institutions as important subjects of insurance relations in national health care.</p><p><strong>Materials and methods.</strong> The study used data from the regulatory framework governing the accounting and reporting system in pharmacies, as well as data from special literature. The historical, analytical-comparative, system, logical, hypothetical-deductive, mathematical-statistical methods of scientific search and cognition are used.</p><p><strong>Results. </strong>As a result of the conducted research, the main directions and four stages (preliminary, organizational, administrative, evaluated and effective, managerial) were justified in analyzing the effectiveness of pharmacy institutions in terms of introducing insurance relationships. An updated scorecard has been proposed, which contains 29 indicators, divided into two types depending on their content, the specifics of calculations and use in the analysis. The first type (8 indicators) were those that characterize the pharmacy insurance recipe. Use in the analysis of indicators of the second (21 indicators) types allow to evaluate the efficiency of the financial component in the insurance activities of pharmacies. When calculating the indicators can be used natural, cost and temporary accounting meters. The use of indicators describing the state of receivables of business entities in the system of pharmaceutical provision of the population in the analysis of insurance activity of pharmacies is substantiated.</p><p><strong>Conclusions. </strong>The effective use of data from the analysis of insurance activities of pharmacies allows you to improve their social status in the system of pharmaceutical provision of the population. An important direction of prospective studies is the rationing of indicators, taking into account the specifics of pharmacy activities, depending on their form of ownership and management in the pharmaceutical market of Ukraine</p>
Authors and Affiliations
Hanna Panfilova, Liliia Нala
Keywords
Related Articles
- EP ID EP647856
- DOI 10.15587/2519-4852.2019.177766
- Views 133
- Downloads 0
In vitro susceptibility study of Candida Spp. isolates to new combined potential medicinal product for the treatment of vaginal candidiasis
<p>Research of the antimicrobial action of model specimens of a potential drug in various fixed combinations and the advent of specific antimycotic activity of model samples of a new, combined, potential drug and medicin...
Первинний аналіз та пріоритезація ризиків процедури біовейвер
<p><strong>Мета</strong><strong>:</strong> Проведення причинно-наслідкового аналізу ідентифікованих ризиків, ранжування та визначення пріоритетів згідно методології загального оцінювання ризиків для забезпечення належног...
Development of composition and technology of combination drug with neurally mediated action «Memofit»
<p> </p><p><strong>Aim. </strong>The aim of this work is to<strong> </strong>develop composition of combination drug in the form of hard-gelatin capsules «Memofit», determine technological and microbiological parameters...
Cycloalkanecarbaldehydes in synthesis of novel 1,2-benzoxathiin-4(3H)-on 2,2-dioxide derivatives and study of the antimicrobial activity of synthesized compounds
<p><strong>Purpose: </strong>This paper is dedicated to the investigation of cycloalkanecarbaldehydes, 1,2-benzoxathiin-4(3H)-on 2,2-dioxide and active methylene nitriles interaction and to studying antimicrobial propert...
Study of the inulin complex of dahlia root bulbs of Ken's flame species and its standardization
<p>The literature data analysis has shown that phytopolysaccharides are perspective sources for study and development of active pharmaceutical ingredients, and can be used as new medicines or biologically active additive...